1. Nestor MS, Ablon G, Gade A, Han H, Fischer DL. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021 Dec;20(12):3759-3781. doi: 10.1111/jocd.14537. Epub 2021 Nov 6. PMID: 34741573; PMCID: PMC9298335.
2. Zito PM. Finasteride. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. Finasteride selectively inhibits type II 5α-reductase, reducing conversion of testosterone to dihydrotestosterone.
3. “FINASTERIDE tablet, film coated” DailyMed. U.S. National Library of Medicine. Mechanism of action section describing inhibition of testosterone to DHT conversion.
4. Ustuner ET. Cause of Androgenic Alopecia: Crux of the Matter. PMC Articles via NCBI. Description of DHT’s role in follicle miniaturization.
Disclaimer:
Compounded medications are specially prepared for individual patient needs based on a valid prescription and, as such, are not reviewed or approved by the U.S. Food and Drug Administration (FDA) for safety or efficacy. These statements have not been evaluated by the FDA.
This information is for educational and informational purposes only. It is not medical advice or a health, diagnosis, or a treatment recommendation. Always consult your healthcare provider before starting any new medication to determine whether it is appropriate for your individual circumstances. Contact your healthcare provider with any questions regarding a medical condition.